Bristol Myers Squibb Net Income 2012-2026 | BMY

Bristol Myers Squibb annual/quarterly net income history and growth rate from 2012 to 2026. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.

Bristol Myers Squibb net income for the quarter ending June 30, 2026 was $3.317B, a 153.21% increase year-over-year.
Bristol Myers Squibb net income for the twelve months ending June 30, 2026 was $9.282B, a 83.84% increase year-over-year.
Bristol Myers Squibb annual net income for 2025 was $7.054B, a 178.83% decline from 2024.
Bristol Myers Squibb annual net income for 2024 was $-8.948B, a 211.5% decline from 2023.
Bristol Myers Squibb annual net income for 2023 was $8.025B, a 26.84% increase from 2022.

Bristol Myers Squibb Annual Net Income (Millions of US $)
2025	$7,054
2024	$-8,948
2023	$8,025
2022	$6,327
2021	$6,994
2020	$-9,015
2019	$3,439
2018	$4,920
2017	$1,007
2016	$4,457
2015	$1,565
2014	$2,004
2013	$2,563
2012	$1,959
2011	$3,701

Bristol Myers Squibb Quarterly Net Income (Millions of US $)
2026-06-30	$3,317
2026-03-31	$2,677
2025-12-31	$1,087
2025-09-30	$2,201
2025-06-30	$1,310
2025-03-31	$2,456
2024-12-31	$72
2024-09-30	$1,211
2024-06-30	$1,680
2024-03-31	$-11,911
2023-12-31	$1,762
2023-09-30	$1,928
2023-06-30	$2,073
2023-03-31	$2,262
2022-12-31	$2,022
2022-09-30	$1,606
2022-06-30	$1,421
2022-03-31	$1,278
2021-12-31	$2,372
2021-09-30	$1,546
2021-06-30	$1,055
2021-03-31	$2,021
2020-12-31	$-10,027
2020-09-30	$1,872
2020-06-30	$-85
2020-03-31	$-775
2019-12-31	$-1,056
2019-09-30	$1,353
2019-06-30	$1,432
2019-03-31	$1,710
2018-12-31	$1,160
2018-09-30	$1,901
2018-06-30	$373
2018-03-31	$1,486
2017-12-31	$-2,328
2017-09-30	$845
2017-06-30	$916
2017-03-31	$1,574
2016-12-31	$894
2016-09-30	$1,202
2016-06-30	$1,166
2016-03-31	$1,195
2015-12-31	$-197
2015-09-30	$706
2015-06-30	$-130
2015-03-31	$1,186
2014-12-31	$13
2014-09-30	$721
2014-06-30	$333
2014-03-31	$937
2013-12-31	$726
2013-09-30	$692
2013-06-30	$536
2013-03-31	$609
2012-12-31	$924
2012-09-30	$-711
2012-06-30	$645
2012-03-31	$1,101
2011-12-31	$850
2011-09-30	$967

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$129.917B	$48.194B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.

Stock Name	Country	Market Cap	PE Ratio
AstraZeneca (AZN)	United Kingdom	$252.627B	16.77
Amgen (AMGN)	United States	$203.467B	16.82
Gilead Sciences (GILD)	United States	$183.117B	0.00
Vertex Pharmaceuticals (VRTX)	United States	$130.268B	30.16
GSK (GSK)	United Kingdom	$101.722B	10.56
Regeneron Pharmaceuticals (REGN)	United States	$79.750B	19.88
Argenex SE (ARGX)	Netherlands	$61.603B	37.81
CSL (CSLLY)	Australia	$59.105B	0.00
Moderna (MRNA)	United States	$58.137B	0.00
Revolution Medicines (RVMD)	United States	$41.993B	0.00
Illumina (ILMN)	United States	$34.568B	44.45
Royalty Pharma (RPRX)	United States	$33.620B	11.14
Alnylam Pharmaceuticals (ALNY)	United States	$32.029B	44.49
Biogen (BIIB)	United States	$31.916B	15.46
Roivant Sciences (ROIV)	United Kingdom	$28.582B	0.00
Insmed (INSM)	United States	$26.769B	0.00
Incyte (INCY)	United States	$25.287B	15.71
BioNTech SE (BNTX)	Germany	$24.234B	0.00
Guardant Health (GH)	United States	$23.471B	0.00
Genmab (GMAB)	Denmark	$21.458B	24.75
Genmab (GNMSF)	Denmark	$20.995B	24.41
Exact Sciences (EXAS)	United States	$19.699B	2581.00
Swedish Orphan Biovitrum (BIOVF)	Sweden	$17.133B	22.81
Jazz Pharmaceuticals (JAZZ)	Ireland	$15.813B	10.55
Ascendis Pharma (ASND)	Denmark	$15.450B	137.61
Exelixis (EXEL)	United States	$14.069B	17.97
Sino Biopharmaceutical (SBMFF)	Hong Kong, SAR China	$13.133B	0.00
BioMarin Pharmaceutical (BMRN)	United States	$12.530B	38.53
Halozyme Therapeutics (HALO)	United States	$12.308B	22.00
Bio-Techne Corp (TECH)	United States	$11.343B	42.05
Axsome Therapeutics (AXSM)	United States	$11.103B	0.00
Krystal Biotech (KRYS)	United States	$9.965B	42.19
Nuvalent (NUVL)	United States	$9.793B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$9.762B	39.34
Repligen (RGEN)	United States	$9.758B	87.77
Kymera Therapeutics (KYMR)	United States	$9.673B	0.00
Arrowhead Pharmaceuticals (ARWR)	United States	$9.267B	0.00
Protagonist Therapeutics (PTGX)	United States	$9.243B	138.68
Twist Bioscience (TWST)	United States	$8.972B	0.00
Abivax SA (ABVX)	France	$8.920B	0.00
QIAGEN (QGEN)	Netherlands	$8.841B	17.71
Vaxcyte (PCVX)	United States	$8.745B	0.00
Cytokinetics (CYTK)	United States	$8.634B	0.00
Praxis Precision Medicines (PRAX)	United States	$8.627B	0.00
TG Therapeutics (TGTX)	United States	$8.549B	20.02
Apogee Therapeutics (APGE)	United States	$8.402B	0.00
ImmunityBio (IBRX)	United States	$8.383B	0.00
Spyre Therapeutics (SYRE)	United States	$8.017B	0.00
Alkermes (ALKS)	Ireland	$7.729B	107.14
Immunovant (IMVT)	United States	$7.514B	0.00
Cidara Therapeutics (CDTX)	United States	$6.960B	0.00
Merus (MRUS)	Netherlands	$6.826B	0.00
Belite Bio (BLTE)	United States	$6.814B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$6.717B	0.00
Arcellx (ACLX)	United States	$6.715B	0.00
CG Oncology (CGON)	United States	$6.570B	0.00
Mirum Pharmaceuticals (MIRM)	United States	$6.322B	0.00
Liquidia (LQDA)	United States	$6.127B	49.96
Terns Pharmaceuticals (TERN)	United States	$6.074B	0.00
Kiniksa Pharmaceuticals (KNSA)	United Kingdom	$6.056B	80.02
Scholar Rock Holding (SRRK)	United States	$6.013B	0.00
Travere Therapeutics (TVTX)	United States	$5.984B	0.00
Cogent Biosciences (COGT)	United States	$5.647B	0.00
PTC Therapeutics (PTCT)	United States	$5.641B	0.00
Dianthus Therapeutics (DNTH)	United States	$5.603B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$5.487B	0.00
Ligand Pharmaceuticals (LGND)	United States	$5.486B	29.43
Erasca (ERAS)	United States	$5.372B	0.00
Apellis Pharmaceuticals (APLS)	United States	$5.214B	313.77
CRISPR Therapeutics AG (CRSP)	Switzerland	$5.048B	0.00
Edgewise Therapeutics (EWTX)	United States	$4.935B	0.00
ACADIA Pharmaceuticals (ACAD)	United States	$4.745B	44.42
Parabilis Medicines (PBLS)	United States	$4.556B	0.00
Amicus Therapeutics (FOLD)	United States	$4.540B	482.00
Akero Therapeutics (AKRO)	United States	$4.499B	0.00
Iovance Biotherapeutics (IOVA)	United States	$4.471B	0.00
Adaptive Biotechnologies (ADPT)	United States	$4.416B	0.00
Veradermics (MANE)	United States	$4.279B	0.00
Celcuity (CELC)	United States	$4.041B	0.00
Telix Pharmaceuticals (TLX)	Australia	$4.020B	0.00
Tango Therapeutics (TNGX)	United States	$3.937B	0.00
AbCellera Biologics (ABCL)	Canada	$3.578B	0.00
Viking Therapeutics (VKTX)	United States	$3.444B	0.00
Tarsus Pharmaceuticals (TARS)	United States	$3.407B	0.00
GRAIL (GRAL)	United States	$3.355B	0.00
IDEAYA Biosciences (IDYA)	United States	$3.315B	0.00
Legend Biotech (LEGN)	United States	$3.294B	0.00
Arcutis Biotherapeutics (ARQT)	United States	$3.286B	124.48
Denali Therapeutics (DNLI)	United States	$3.207B	0.00
Arcus Biosciences (RCUS)	United States	$3.139B	0.00
Zealand Pharma (ZLDPF)	Denmark	$3.076B	7.13
Celldex Therapeutics (CLDX)	United States	$3.040B	0.00
MBX Biosciences (MBX)	United States	$2.965B	0.00
UniQure (QURE)	Netherlands	$2.947B	0.00
Regencell Bioscience Holdings (RGC)	Hong Kong, SAR China	$2.809B	0.00
Zai Lab (ZLAB)	China	$2.807B	0.00
AtaiBeckley Inc (ATAI)	Netherlands	$2.726B	0.00
Immunome (IMNM)	United States	$2.665B	0.00
Precigen (PGEN)	United States	$2.651B	0.00
Nurix Therapeutics (NRIX)	United States	$2.610B	0.00
Viridian Therapeutics (VRDN)	United States	$2.542B	0.00
Braveheart Bio (BRVE)	United States	$2.472B	0.00
Structure Therapeutics (GPCR)	United States	$2.472B	0.00
Harmony Biosciences Holdings (HRMY)	United States	$2.458B	13.70
Pharvaris (PHVS)	Netherlands	$2.456B	0.00
Bavarian Nordic (BVNRY)	Denmark	$2.446B	10.39
Mineralys Therapeutics (MLYS)	United States	$2.435B	0.00
NeoGenomics (NEO)	United States	$2.433B	0.00
Beam Therapeutics (BEAM)	United States	$2.386B	0.00
SELLAS Life Sciences (SLS)	United States	$2.355B	0.00
HUTCHMED (China) (HCM)	Hong Kong, SAR China	$2.348B	0.00
Vera Therapeutics (VERA)	United States	$2.289B	0.00
Day One Biopharmaceuticals (DAWN)	United States	$2.218B	0.00
Palvella Therapeutics (PVLA)	United States	$2.182B	0.00
Trevi Therapeutics (TRVI)	United States	$2.139B	0.00
Urogen Pharma (URGN)	United States	$2.126B	0.00
Zenas BioPharma (ZBIO)	United States	$2.107B	0.00
Sarepta Therapeutics (SRPT)	United States	$2.087B	0.00
Kodiak Sciences (KOD)	United States	$2.060B	0.00
Vericel (VCEL)	United States	$2.059B	85.55
Alamar Biosciences (ALMR)	United States	$2.039B	0.00
Nuvation Bio (NUVB)	United States	$2.029B	0.00
Generate Biomedicines (GENB)	United States	$2.013B	0.00
ADMA Biologics Inc (ADMA)	United States	$1.993B	12.53
Rapport Therapeutics (RAPP)	United States	$1.986B	0.00
Agios Pharmaceuticals (AGIO)	United States	$1.967B	0.00
Hemab Therapeutics Holdings (COAG)	United States	$1.914B	0.00
GH Research (GHRS)	Ireland	$1.904B	0.00
Fortrea Holdings (FTRE)	United States	$1.899B	33.28
NovoCure (NVCR)	Jersey	$1.889B	0.00
Mesoblast (MESO)	Australia	$1.872B	0.00
Galapagos (GLPG)	Belgium	$1.871B	0.00
Zymeworks (ZYME)	United States	$1.862B	0.00
Dynavax Technologies (DVAX)	United States	$1.819B	53.41
Biohaven (BHVN)	United States	$1.816B	0.00
Lakefront Biotherapeutics - (LKFT)	Belgium	$1.814B	0.00
Stoke Therapeutics (STOK)	United States	$1.801B	0.00
Septerna (SEPN)	United States	$1.794B	0.00
Vir Biotechnology (VIR)	United States	$1.780B	0.00
Nanobiotix S.A - (NBTX)	France	$1.741B	0.00
Recursion Pharmaceuticals (RXRX)	United States	$1.708B	0.00
Pharma Mar (PHMMF)	Spain	$1.703B	0.00
ANI Pharmaceuticals (ANIP)	United States	$1.690B	10.34
Kailera Therapeutics (KLRA)	United States	$1.646B	0.00
Forte Biosciences (FBRX)	United States	$1.634B	0.00
Immunocore Holdings (IMCR)	United Kingdom	$1.627B	0.00
Eton Pharmaceuticals (ETON)	United States	$1.611B	148.29
Intellia Therapeutics (NTLA)	United States	$1.610B	0.00
AnaptysBio (ANAB)	United States	$1.608B	0.00
Rapt Therapeutics (RAPT)	United States	$1.599B	0.00
Novavax (NVAX)	United States	$1.542B	0.00
Alvotech (ALVO)	Luxembourg	$1.539B	0.00
Avalyn Pharma (AVLN)	United States	$1.539B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$1.531B	0.00
Latigo Biotherapeutics Inc (LTGO)	United States	$1.529B	0.00
Galecto (DMRA)	Denmark	$1.514B	0.00
Inhibrx Biosciences (INBX)	United States	$1.498B	0.00
Mind Medicine (MindMed) (MNMD)	United States	$1.480B	0.00
Bicara Therapeutics (BCAX)	United States	$1.456B	0.00
Tyra Biosciences (TYRA)	United States	$1.453B	0.00
Ascentage Pharma Group - (AAPG)	China	$1.438B	0.00
First Tracks Biotherapeutics (TRAX)	United States	$1.394B	0.00
Absci (ABSI)	United States	$1.380B	0.00
LB Pharmaceuticals Inc (LBRX)	United States	$1.373B	0.00
ArriVent BioPharma (AVBP)	United States	$1.363B	0.00
Maze Therapeutics (MAZE)	United States	$1.328B	0.00
Cullinan Therapeutics (CGEM)	United States	$1.328B	0.00
Oric Pharmaceuticals (ORIC)	United States	$1.300B	0.00
Vor Biopharma (VOR)		$1.299B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$1.270B	0.00
Certara (CERT)	United States	$1.240B	33.88
MeiraGTx Holdings (MGTX)	United States	$1.226B	17.97
Replimune (REPL)	United States	$1.216B	0.00
Immatics (IMTX)	Germany	$1.181B	0.00
Alto Neuroscience (ANRO)	United States	$1.177B	0.00
MannKind (MNKD)	United States	$1.141B	0.00
Odyssey Therapeutics (ODTX)	United States	$1.111B	0.00
Castle Biosciences (CSTL)	United States	$1.084B	0.00
Monte Rosa Therapeutics (GLUE)	United States	$1.079B	0.00
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.060B	0.00
Obsidian Therapeutics (OBX)	United States	$1.059B	0.00
Jade Biosciences (JBIO)	United States	$1.059B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$1.029B	0.00
Alumis (ALMS)	United States	$1.028B	0.00
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$1.019B	0.00
Attovia Therapeutics (ATTO)	United States	$1.016B	0.00
SL SCIENCE HLDG (SLBT)		$1.015B	0.00
Ventyx Biosciences (VTYX)	United States	$1.003B	0.00
Arbutus Biopharma (ABUS)	United States	$1.000B	6.39
Adlai Nortye (ANL)	Cayman Islands	$0.999B	0.00
Kura Oncology (KURA)	United States	$0.996B	0.00
Janux Therapeutics (JANX)	United States	$0.993B	0.00
Pacira BioSciences (PCRX)	United States	$0.993B	15.97
SpyGlass Pharma (SGP)	United States	$0.956B	0.00
Solid Biosciences (SLDB)	United States	$0.935B	0.00
CureVac (CVAC)	Germany	$0.927B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.899B	0.00
WAVE Life Sciences (WVE)	Singapore	$0.888B	0.00
Faeth Therapeutics (FTH)	United States	$0.885B	0.00
Sana Biotechnology (SANA)	United States	$0.874B	0.00
Immix Biopharma (IMMX)	United States	$0.853B	0.00
Olema Pharmaceuticals (OLMA)	United States	$0.851B	0.00
Candel Therapeutics (CADL)	United States	$0.843B	0.00
Geron (GERN)	United States	$0.829B	0.00
Climb Bio (CLYM)	United States	$0.810B	0.00
BlossomHill Therapeutics (BLSM)	United States	$0.804B	0.00
Anbio Biotechnology (NNNN)	Germany	$0.803B	0.00
Inventiva S.A (IVA)	France	$0.787B	0.00
Design Therapeutics (DSGN)	United States	$0.783B	0.00
Pharming Group (PHAR)	Netherlands	$0.750B	88.33
Gyre Therapeutics (GYRE)	United States	$0.747B	0.00
Annexon (ANNX)	United States	$0.745B	0.00
Pharming Group (PHGUF)	Netherlands	$0.742B	92.08
DBV Technologies S.A (DBVT)	France	$0.741B	0.00
Astria Therapeutics (ATXS)	United States	$0.718B	0.00
Nuvectis Pharma (NVCT)	United States	$0.714B	0.00
Aura Biosciences (AURA)	United States	$0.698B	0.00
Neurogene (NGNE)	United States	$0.694B	0.00
MiMedx (MDXG)	United States	$0.689B	24.90
Monopar Therapeutics (MNPR)	United States	$0.681B	0.00
Verastem (VSTM)	United States	$0.663B	0.00
Sagimet Biosciences (SGMT)	United States	$0.650B	0.00
Starling Oncology (STLN)	United States	$0.645B	0.00
Sinovac Biotech (SVA)	China	$0.645B	0.00
Cytek Biosciences (CTKB)	United States	$0.641B	0.00
Crescent Biopharma (CBIO)	United States	$0.638B	0.00
Oxford BioMedica (OXBDF)	United Kingdom	$0.635B	0.00
Phathom Pharmaceuticals (PHAT)	United States	$0.622B	0.00
CorMedix Inc (CRMD)	United States	$0.610B	4.12
CytomX Therapeutics (CTMX)	United States	$0.602B	0.00
Shattuck Labs (STTK)	United States	$0.590B	0.00
Allogene Therapeutics (ALLO)	United States	$0.584B	0.00
Bright Minds Biosciences (DRUG)	United States	$0.575B	0.00
Oculis Holding AG (OCS)	Switzerland	$0.575B	0.00
Scribe Therapeutics (SCTX)		$0.551B	0.00
Tectonic Therapeutic (TECX)	United States	$0.546B	0.00
Prime Medicine (PRME)	United States	$0.544B	0.00
MapLight Therapeutics (MPLT)	United States	$0.529B	0.00
REGENXBIO (RGNX)	United States	$0.527B	0.00
Arvinas (ARVN)	United States	$0.526B	81.60
Eupraxia Pharmaceuticals (EPRX)	Canada	$0.526B	0.00
Ovid Therapeutics (OVID)	United States	$0.523B	0.00
Contineum Therapeutics (CTNM)	United States	$0.518B	0.00
Entera Bio (ENTX)	Israel	$0.515B	0.00
XOMA Royalty (XOMA)	United States	$0.504B	95.64
Autolus Therapeutics (AUTL)	United Kingdom	$0.498B	0.00
Puma Biotechnology (PBYI)	United States	$0.485B	18.06
Ginkgo Bioworks Holdings (DNA)	United States	$0.475B	0.00
Kamada (KMDA)	Israel	$0.471B	21.55
Vogenx Inc (VOGX)	United States	$0.465B	0.00
Eikon Therapeutics (EIKN)	United States	$0.461B	0.00
Opus Genetics (IRD)	United States	$0.447B	0.00
Arcturus Therapeutics Holdings (ARCT)	United States	$0.443B	0.00
Zura Bio (ZURA)	United States	$0.442B	0.00
Prothena (PRTA)	Ireland	$0.431B	0.00
Kyverna Therapeutics (KYTX)	United States	$0.427B	0.00
C4 Therapeutics (CCCC)	United States	$0.424B	0.00
Cabaletta Bio (CABA)	United States	$0.422B	0.00
Artiva Biotherapeutics (ARTV)	United States	$0.420B	0.00
PureTech Health (PRTCY)	United States	$0.418B	0.00
Editas Medicine (EDIT)	United States	$0.416B	0.00
AgomAb Therapeutics (AGMB)	Belgium	$0.413B	0.00
Atea Pharmaceuticals (AVIR)	United States	$0.413B	0.00
Turn Therapeutics (TTRX)	United States	$0.409B	0.00
PureTech Health (PRTC)	United States	$0.402B	0.00
GENFIT S.A (GNFTY)	France	$0.391B	0.00
Benitec Biopharma (BNTC)	United States	$0.385B	0.00
Rezolute (RZLT)	United States	$0.383B	0.00
Rocket Pharmaceuticals (RCKT)	United States	$0.382B	0.00
BridgeBio Oncology Therapeutics (BBOT)	United States	$0.382B	0.00
Alpha Teknova (TKNO)	United States	$0.381B	0.00
Prenetics Global (PRE)	Hong Kong, SAR China	$0.372B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$0.370B	0.00
Adherex Technologies (FENC)	United States	$0.370B	0.00
Myriad Genetics (MYGN)	United States	$0.369B	0.00
Orchestra BioMed Holdings (OBIO)	United States	$0.361B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.358B	0.00
BioAge Labs (BIOA)	United States	$0.356B	0.00
X4 Pharmaceuticals (XFOR)	United States	$0.348B	0.00
Emergent Biosolutions (EBS)	United States	$0.346B	4.69
Evommune (EVMN)	United States	$0.340B	0.00
Ocugen (OCGN)	United States	$0.339B	0.00
Compass Therapeutics (CMPX)	United States	$0.330B	0.00
Q32 Bio (QTTB)	United States	$0.327B	5.30
Agenus (AGEN)	United States	$0.326B	2.05
Sionna Therapeutics (SION)	United States	$0.318B	0.00
SAB Biotherapeutics (SABS)	United States	$0.308B	0.00
Abeona Therapeutics (ABEO)	United States	$0.307B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.302B	0.00
InflaRx (IFRX)	Germany	$0.301B	0.00
EyePoint (EYPT)	United States	$0.297B	0.00
Palisade Bio (PALI)	United States	$0.295B	0.00
Fate Therapeutics (FATE)	United States	$0.292B	0.00
Amarin (AMRN)	Ireland	$0.292B	0.00
Upstream Bio (UPB)	United States	$0.292B	0.00
Fulcrum Therapeutics (FULC)	United States	$0.289B	0.00
Immuneering (IMRX)	United States	$0.288B	0.00
Northwest Biotherapeutics (NWBO)	United States	$0.286B	0.00
Anika Therapeutics (ANIK)	United States	$0.279B	1042.00
AC Immune (ACIU)	Switzerland	$0.270B	0.00
Entrada Therapeutics (TRDA)	United States	$0.268B	0.00
Disc Medicine (IRON)	United States	$0.263B	0.00
YD Bio (YDES)		$0.262B	0.00
Sutro Biopharma (STRO)	United States	$0.259B	0.00
Starpharma Holdings (SPHRY)	Australia	$0.256B	0.00
Bicycle Therapeutics (BCYC)	United Kingdom	$0.255B	0.00
Cue Biopharma (CUE)	United States	$0.248B	0.00
Foghorn Therapeutics (FHTX)	United States	$0.248B	0.00
ALX Oncology Holdings (ALXO)	United States	$0.243B	0.00
CAMP4 Therapeutics (CAMP)	United States	$0.242B	0.00
Cartesian Therapeutics (RNAC)	United States	$0.239B	0.00
Adocia (ADOCY)	France	$0.239B	0.00
Niagen Bioscience (NAGE)	United States	$0.239B	18.75
Invivyd (IVVD)	United States	$0.237B	0.00
Whitehawk Therapeutics (WHWK)	United States	$0.230B	0.00
Greenwich LifeSciences (GLSI)	United States	$0.229B	0.00
Compugen (CGEN)	Israel	$0.228B	6.34
Innate Pharma S.A (IPHA)	France	$0.225B	0.00
Zentalis Pharmaceuticals (ZNTL)	United States	$0.222B	0.00
Anavex Life Sciences (AVXL)	United States	$0.219B	0.00
Eledon Pharmaceuticals (ELDN)	United States	$0.217B	0.00
Alector (ALEC)	United States	$0.215B	0.00
Keros Therapeutics (KROS)	United States	$0.213B	0.00
Adagene (ADAG)	China	$0.209B	0.00
Nkarta (NKTX)	United States	$0.206B	0.00
AN2 Therapeutics (ANTX)	United States	$0.202B	0.00
PepGen (PEPG)	United States	$0.201B	0.00
Satellos Bioscience (MSLE)	Canada	$0.197B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.196B	0.00
Acumen Pharmaceuticals (ABOS)	United States	$0.189B	0.00
Coherus Oncology (CHRS)	United States	$0.188B	0.00
Voyager Therapeutics (VYGR)	United States	$0.188B	0.00
Precision BioSciences (DTIL)	United States	$0.183B	0.00
Alpha Cognition (ACOG)	Canada	$0.183B	0.00
NovaBridge Biosciences (NBP)	United States	$0.182B	0.00
NervGen Pharma (NGEN)	Canada	$0.172B	0.00
Tharimmune (THAR)	United States	$0.169B	0.00
Outlook Therapeutics (OTLK)	United States	$0.165B	0.00
Humacyte (HUMA)	United States	$0.158B	0.00
Molecular Partners AG (MOLN)	Switzerland	$0.158B	0.00
Lifecore Biomedical (LFCR)	United States	$0.157B	0.00
Jyong Biotech (MENS)	Taiwan	$0.157B	0.00
Spruce Biosciences (SPRB)	United States	$0.156B	0.00
Tenaya Therapeutics (TNYA)	United States	$0.147B	0.00
Codexis (CDXS)	United States	$0.147B	0.00
Mersana Therapeutics (MRSN)	United States	$0.145B	0.00
Neumora Therapeutics (NMRA)	United States	$0.145B	0.00
Immunic (IMUX)	United States	$0.138B	0.00
Cellectis S.A (CLLS)	France	$0.138B	0.00
ADC Therapeutics SA (ADCT)	Switzerland	$0.134B	0.00
Caribou Biosciences (CRBU)	United States	$0.134B	0.00
Novogen (KZIA)	Australia	$0.132B	0.00
Conexeu Sciences (CNXU)	United States	$0.130B	0.00
LENZ Therapeutics (LENZ)	United States	$0.130B	0.00
TuHURA Biosciences (HURA)	United States	$0.129B	0.00
EnGene Therapeutics Inc (ENGN)	Canada	$0.128B	0.00
Biomea Fusion (BMEA)	United States	$0.126B	0.00
MediciNova (MNOV)	United States	$0.124B	0.00
Nautilus Biotechnology (NAUT)	United States	$0.124B	0.00
MaxCyte (MXCT)	United States	$0.122B	0.00
VTv Therapeutics (VTVT)	United States	$0.120B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.119B	0.00
Equillium (EQ)	United States	$0.118B	0.00
OnKure Therapeutics (OKUR)	United States	$0.116B	0.00
Promis Neurosciences (PMN)	Canada	$0.116B	0.00
Repare Therapeutics (RPTX)	Canada	$0.114B	0.00
Aardvark Therapeutics (AARD)	United States	$0.113B	0.00
Black Diamond Therapeutics (BDTX)	United States	$0.111B	0.00
Milestone Pharmaceuticals (MIST)	Canada	$0.111B	0.00
Lixte Biotechnology Holdings (LIXT)	United States	$0.108B	0.00
Genelux (GNLX)	United States	$0.106B	0.00
Rani Therapeutics Holdings (RANI)	United States	$0.105B	0.00
Seer (SEER)	United States	$0.105B	0.00
Cardiff Oncology (CRDF)	United States	$0.105B	0.00
Coya Therapeutics (COYA)	United States	$0.105B	0.00
Atara Biotherapeutics (ATRA)	United States	$0.101B	0.00
Polaryx Therapeutics (PLYX)	United States	$0.101B	0.00
Oncolytics Biotech (ONCY)	United States	$0.098B	0.00
Tiziana Life Sciences (TLSA)	United Kingdom	$0.098B	0.00
Cognition Therapeutics (CGTX)	United States	$0.097B	0.00
Chrome Holding (MEHCQ)	United States	$0.096B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.096B	0.00
Rallybio (RLYB)	United States	$0.091B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.090B	0.00
Citius Oncology (CTOR)	United States	$0.089B	0.00
Adicet Bio (ACET)	United States	$0.085B	0.00
Fortress Biotech (FBIO)	United States	$0.082B	0.93
Connect Biopharma Holdings (CNTB)	United States	$0.078B	0.00
IBio (IBIO)	United States	$0.076B	0.00
Kalaris Therapeutics (KLRS)	United States	$0.076B	0.00
Coeptis Therapeutics Holdings (COEP)	United States	$0.074B	0.00
Cingulate (CING)	United States	$0.074B	0.00
BioStem Technologies (BSEM)		$0.073B	0.00
Senesco Technologies (ELOX)	United States	$0.071B	0.00
RenovoRx (RNXT)	United States	$0.070B	0.00
OKYO Pharma (OKYO)		$0.070B	0.00
Alterity Therapeutics - (ATHE)	Australia	$0.070B	0.00
Yarrow Bioscience (YARW)	United States	$0.069B	0.00
Tenax Therapeutics (TENX)	United States	$0.068B	0.00
Alps Group (ALPS)		$0.067B	1.21
Pliant Therapeutics (PLRX)	United States	$0.066B	0.00
XBiotech (XBIT)	United States	$0.066B	0.00
Zhengye Biotechnology Holding (ZYBT)	China	$0.065B	0.00
Spero Therapeutics (SPRO)	United States	$0.065B	10.09
Boundless Bio (BOLD)	United States	$0.064B	0.00
LeonaBio (LONA)	United States	$0.064B	0.00
Sangamo Therapeutics (SGMOQ)	United States	$0.061B	0.00
Rein Therapeutics (RNTX)	United States	$0.061B	0.00
MiNK Therapeutics (INKT)	United States	$0.059B	0.00
Xilio Therapeutics (XLO)	United States	$0.059B	0.00
Dogwood Therapeutics (DWTX)	United States	$0.058B	0.00
EXoZymes (EXOZ)	United States	$0.057B	0.00
INmune Bio (INMB)	United States	$0.057B	0.00
ImageneBio (IMA)	United States	$0.056B	0.00
PDS Biotechnology (PDSB)	United States	$0.055B	0.00
Kezar Life Sciences (KZR)	United States	$0.054B	0.00
TELA Bio (TELA)	United States	$0.053B	0.00
Clene (CLNN)	United States	$0.050B	0.00
Instil Bio (TIL)	United States	$0.049B	0.00
Apollomics (APLM)	United States	$0.049B	0.00
Prima BioMed (IMMP)	Australia	$0.048B	0.00
Elicio Therapeutics (ELTX)	United States	$0.047B	0.00
Galecto (GLTO)	Denmark	$0.047B	0.00
Grace Therapeutics (GRCE)	United States	$0.045B	0.00
Werewolf Therapeutics (HOWL)	United States	$0.045B	0.00
Annovis Bio (ANVS)	United States	$0.044B	0.00
Scilex Holding (SCLX)	United States	$0.044B	0.00
Mereo BioPharma Group - (MREO)	United Kingdom	$0.042B	0.00
Seres Therapeutics (MCRB)	United States	$0.042B	0.00
Sensei Biotherapeutics (SNSE)	United States	$0.040B	0.00
Generation Bio (GBIO)	United States	$0.038B	0.00
ATyr Pharma (ATYR)	United States	$0.038B	0.00
Celularity (CELU)	United States	$0.037B	0.00
Edesa Biotech (EDSA)	Canada	$0.037B	0.00
CervoMed (CRVO)	United States	$0.037B	0.00
Elutia (ELUT)	United States	$0.036B	0.00
Cassava Sciences (FLNA)	United States	$0.033B	0.00
BioHarvest Sciences (BHST)	Canada	$0.033B	0.00
Gossamer Bio (GOSS)	United States	$0.032B	0.00
Aligos Therapeutics (ALGS)	United States	$0.032B	0.00
BRIACELL THERAP (BCTX)	Canada	$0.031B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.031B	0.00
MIRA Pharmaceuticals (MIRA)	United States	$0.030B	0.00
Barinthus Biotherapeutics (BRNS)	United States	$0.030B	0.00
BeyondSpring (BYSI)	United States	$0.029B	0.00
ABVC BioPharma (ABVC)	United States	$0.029B	0.00
Estrella Immunopharma (ESLA)	United States	$0.028B	0.00
Quince Therapeutics (QNCX)	United States	$0.028B	0.00
Athira Pharma (ATHA)	United States	$0.027B	0.00
IO Biotech (IOBT)	Denmark	$0.027B	0.00
BGM Group (BGM)	China	$0.025B	0.00
Lantern Pharma (LTRN)	United States	$0.025B	0.00
Atossa Therapeutics (ATOS)	United States	$0.024B	0.00
Radiopharm Theranostics - (RADX)	Australia	$0.024B	0.00
Actuate Therapeutics (ACTU)	United States	$0.024B	0.00
Quantum Biopharma (QNTM)	Canada	$0.023B	0.00
Tvardi Therapeutics (TVRD)	United States	$0.023B	0.00
Polyrizon (PLRZ)	Israel	$0.023B	0.00
TScan Therapeutics (TCRX)	United States	$0.022B	0.00
Cocrystal Pharma (COCP)	United States	$0.022B	0.00
NextCure (NXTC)	United States	$0.022B	0.00
Longeveron (LGVN)	United States	$0.021B	0.00
Femasys (FEMY)	United States	$0.021B	0.00
Aytu BioPharma (AYTU)	United States	$0.021B	0.00
Cyclerion Therapeutics (KRSA)	United States	$0.021B	0.00
Neuphoria Therapeutics (NEUP)	United States	$0.020B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.020B	0.00
NewcelX (NCEL)	Switzerland	$0.020B	0.00
Jasper Therapeutics (JSPR)	United States	$0.019B	0.00
Quantum Cyber N.V (QUCY)	United States	$0.019B	0.00
Chemomab Therapeutics (CMMB)	Israel	$0.019B	0.00
BioCardia (BCDA)	United States	$0.019B	0.00
Allarity Therapeutics (ALLR)	United States	$0.018B	0.00
Biofrontera (BFRI)	United States	$0.018B	0.00
Bionano Genomics (BNGO)	United States	$0.018B	0.00
Genenta Science S.p.A (GNTA)	Italy	$0.017B	0.00
Palatin Technologies (PTN)	United States	$0.017B	0.00
Pasithea Therapeutics (KTTA)	United States	$0.016B	0.00
Dyadic (DYAI)	United States	$0.016B	0.00
Cyclerion Therapeutics (CYCN)	United States	$0.016B	0.00
Passage Bio (PASG)	United States	$0.016B	0.00
Cerenome (CNSY)	United States	$0.015B	0.00
Moleculin Biotech (MBRX)	United States	$0.014B	0.00
Dare Bioscience (DARE)	United States	$0.014B	0.00
Applied Therapeutics (APLT)	United States	$0.014B	0.00
GT Biopharma (GTBP)	United States	$0.014B	0.00
Pluri (PLUR)	Israel	$0.014B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.014B	0.00
CalciMedica (CALC)	United States	$0.014B	0.00
Psyence Biomedical (PBM)	Canada	$0.013B	0.00
Lisata Therapeutics (LSTA)	United States	$0.013B	0.00
Advanced Biomed (ADVB)	United States	$0.013B	1.54
Intensity Therapeutics (INTS)	United States	$0.012B	0.00
NeuroSense Therapeutics (NRSN)	Israel	$0.012B	0.00
Aspire Biopharma Holdings (ASBP)	United States	$0.012B	0.00
CytoMed Therapeutics (GDTC)	Singapore	$0.010B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.010B	0.00
KALA BIO (KALA)	United States	$0.010B	0.00
IN8bio (INAB)	United States	$0.010B	0.00
Medicus Pharma (MDCX)	United States	$0.010B	0.00
Senti Biosciences (SNTI)	United States	$0.010B	0.00
IMMURON (IMRN)	Australia	$0.010B	0.00
FibroBiologics (FBLG)	United States	$0.010B	0.00
Aprea Therapeutics (APRE)	United States	$0.009B	0.00
Alzamend Neuro (ALZN)	United States	$0.009B	0.00
Ensysce Biosciences (ENSC)	United States	$0.009B	0.00
Exicure (XCUR)	United States	$0.009B	0.00
Hoth Therapeutics (HOTH)	United States	$0.008B	0.00
CNS Pharmaceuticals (CNSP)	United States	$0.008B	0.00
MetaVia (MTVA)	United States	$0.008B	0.00
Imunon (IMNN)	United States	$0.008B	0.00
Acurx Pharmaceuticals (ACXP)	United States	$0.008B	0.00
Skye Bioscience (SKYE)	United States	$0.008B	0.00
Mainz Biomed (MYNZ)	Germany	$0.007B	0.00
Bolt Biotherapeutics (BOLT)	United States	$0.007B	0.00
Enveric Biosciences (ENVB)	United States	$0.007B	0.00
Gelteq (GELS)	Australia	$0.006B	0.00
Cardio Diagnostics Holdings (CDIO)	United States	$0.006B	0.00
AquaBounty Technologies (AQB)	United States	$0.006B	0.00
Creative Medical Technology Holdings (CELZ)	United States	$0.005B	0.00
NuCana (NCNA)	United Kingdom	$0.005B	0.00
Soligenix (SNGX)	United States	$0.005B	0.00
Lexaria Bioscience (LEXX)	Canada	$0.005B	0.00
Pulmatrix (PULM)	United States	$0.005B	0.00
CollPlant Biotechnologies (CLGN)	Israel	$0.005B	0.00
Lakewood-Amedex Biotherapeutics (LABT)	United States	$0.005B	0.00
Dermata Therapeutics (DRMA)	United States	$0.005B	0.00
VivoSim Labs (VIVS)	United States	$0.004B	0.00
Evogene (EVGN)	Israel	$0.004B	0.00
Avalon GloboCare (ALBT)	United States	$0.004B	0.00
Sunshine Biopharma (SBFM)	United States	$0.004B	0.00
GRI Bio (GRI)	United States	$0.004B	0.00
Cadrenal Therapeutics (CVKD)	United States	$0.004B	0.00
Black Titan (BTTC)	United States	$0.004B	0.00
Mustang Bio (MBIO)	United States	$0.004B	0.00
HCW Biologics (HCWB)	United States	$0.004B	0.00
Revelation Biosciences (REVB)	United States	$0.004B	0.00
Biorestorative Therapies (BRTX)	United States	$0.004B	0.00
BioAffinity Technologies (BIAF)	United States	$0.003B	0.00
Aptevo Therapeutics (APVO)	United States	$0.003B	0.00
GeoVax Labs (GOVX)	United States	$0.003B	0.00
Beyond Air (XAIR)	United States	$0.003B	0.00
Onconetix (ONCO)	United States	$0.003B	0.00
GENPREX (GNPX)	United States	$0.003B	0.00
Silo Pharma (SILO)	United States	$0.003B	0.00
Curis (CRIS)	United States	$0.002B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.002B	0.00
Artelo Biosciences (ARTL)	United States	$0.002B	0.00
Abpro Holdings (ABP)	United States	$0.002B	0.00
Virax Biolabs Group (VRAX)	United Kingdom	$0.002B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.002B	0.00
Silexion Therapeutics Corp (SLXN)	Israel	$0.002B	0.00
Valion Bio (VBIO)	United States	$0.002B	0.00
Bone Biologics (BBLG)	United States	$0.001B	0.00
Cuprina Holdings (Cayman) (CUPR)	Singapore	$0.001B	0.00
Propanc Biopharma Inc (PPCB)	Australia	$0.001B	0.00
Purple Biotech (PPBT)	Israel	$0.001B	0.00
Arcadia Biosciences (RKDA)	United States	$0.001B	0.00
Scinai Immunotherapeutics (SCNI)	Israel	$0.001B	0.00
Biodexa Pharmaceuticals (BDRX)	United Kingdom	$0.001B	0.00
Aceragen (ACGN)	United States	$0.000B	0.00
ARAVIVE, INC (ARAV)	United States	$0.000B	0.00
Clovis Oncology (CLVSQ)	United States	$0.000B	0.00
Clinuvel Pharmaceuticals - (CUVL)	Australia	$0.000B	0.00
Celyad SA (CYAD)	Belgium	$0.000B	0.00
Motif Bio Plc (MTFB)	United Kingdom	$0.000B	0.00
PDL BioPharma (PDLI)	United States	$0.000B	0.00
TFF Pharmaceuticals (TFFP)	United States	$0.000B	0.00
VectivBio Holding AG (VECT)	Switzerland	$0.000B	0.00